Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryo Implantation | 5 | 2017 | 278 | 0.830 |
Why?
|
| Endometrium | 3 | 2017 | 470 | 0.690 |
Why?
|
| Fertilization in Vitro | 3 | 2017 | 199 | 0.660 |
Why?
|
| Infertility, Female | 2 | 2017 | 217 | 0.650 |
Why?
|
| Embryo Transfer | 2 | 2017 | 83 | 0.620 |
Why?
|
| Sex Preselection | 1 | 2012 | 8 | 0.430 |
Why?
|
| Ethics, Medical | 1 | 2012 | 442 | 0.320 |
Why?
|
| Transcriptome | 3 | 2017 | 1859 | 0.240 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 830 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 925 | 0.210 |
Why?
|
| Pregnancy | 7 | 2017 | 7573 | 0.180 |
Why?
|
| Diet, Protein-Restricted | 1 | 2019 | 82 | 0.160 |
Why?
|
| Pregnancy, Animal | 1 | 2017 | 92 | 0.150 |
Why?
|
| Menstrual Cycle | 1 | 2017 | 56 | 0.150 |
Why?
|
| Follicular Fluid | 1 | 2016 | 13 | 0.140 |
Why?
|
| Luteal Cells | 1 | 2016 | 10 | 0.140 |
Why?
|
| Folic Acid | 1 | 2019 | 349 | 0.140 |
Why?
|
| Oocytes | 1 | 2019 | 414 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2017 | 145 | 0.140 |
Why?
|
| Uterus | 2 | 2017 | 678 | 0.140 |
Why?
|
| Amino Acids | 1 | 2019 | 728 | 0.130 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2016 | 75 | 0.130 |
Why?
|
| Progesterone | 1 | 2017 | 513 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 694 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 336 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2017 | 1391 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 545 | 0.110 |
Why?
|
| Social Values | 1 | 2012 | 62 | 0.100 |
Why?
|
| Mitochondria | 1 | 2019 | 1282 | 0.100 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 47 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2016 | 2203 | 0.080 |
Why?
|
| Recurrence | 1 | 2017 | 4758 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 2488 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 748 | 0.070 |
Why?
|
| Inflammation | 1 | 2016 | 2522 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 792 | 0.070 |
Why?
|
| Genomics | 1 | 2016 | 2738 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2012 | 3033 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 918 | 0.060 |
Why?
|
| Obesity | 1 | 2016 | 2884 | 0.060 |
Why?
|
| Female | 9 | 2019 | 141928 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 1217 | 0.060 |
Why?
|
| Animals | 5 | 2019 | 59536 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8873 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 5159 | 0.050 |
Why?
|
| Follicular Phase | 1 | 2019 | 16 | 0.040 |
Why?
|
| Cumulus Cells | 1 | 2019 | 44 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8223 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 51 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 252 | 0.040 |
Why?
|
| Role | 1 | 2017 | 48 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 562 | 0.040 |
Why?
|
| Spain | 1 | 2016 | 113 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 6150 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2016 | 6100 | 0.040 |
Why?
|
| California | 1 | 2016 | 208 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 198 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 6942 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 777 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 2049 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 112 | 0.030 |
Why?
|
| Humans | 6 | 2017 | 261506 | 0.030 |
Why?
|
| Chemokines | 1 | 2016 | 314 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 306 | 0.030 |
Why?
|
| United States | 1 | 2012 | 15433 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 974 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1363 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 643 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 677 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2016 | 12873 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 3536 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 3570 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 3101 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 3639 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5637 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 2809 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 7548 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 6311 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 4053 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 6295 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 7226 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 5539 | 0.010 |
Why?
|
| Male | 1 | 2012 | 123000 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 14889 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 17523 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 34495 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 32848 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 77950 | 0.010 |
Why?
|